1. Home
  2. CADL vs RFI Comparison

CADL vs RFI Comparison

Compare CADL & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$4.91

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Steers Total Return Realty Fund Inc.

RFI

Cohen & Steers Total Return Realty Fund Inc.

HOLD

Current Price

$11.42

Market Cap

320.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
RFI
Founded
1999
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
357.4M
320.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CADL
RFI
Price
$4.91
$11.42
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
1.2M
75.4K
Earning Date
05-12-2026
01-01-0001
Dividend Yield
N/A
8.25%
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.34
$10.78
52 Week High
$7.24
$12.18

Technical Indicators

Market Signals
Indicator
CADL
RFI
Relative Strength Index (RSI) 47.13 53.47
Support Level $4.56 $10.91
Resistance Level $5.42 $12.11
Average True Range (ATR) 0.24 0.18
MACD 0.03 0.05
Stochastic Oscillator 62.09 70.89

Price Performance

Historical Comparison
CADL
RFI

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About RFI Cohen & Steers Total Return Realty Fund Inc.

Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.

Share on Social Networks: